Xunda Ji

1.5k total citations
32 papers, 545 citations indexed

About

Xunda Ji is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xunda Ji has authored 32 papers receiving a total of 545 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Ophthalmology, 13 papers in Radiology, Nuclear Medicine and Imaging and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xunda Ji's work include Ocular Oncology and Treatments (19 papers), Retinopathy of Prematurity Studies (8 papers) and Brain Metastases and Treatment (6 papers). Xunda Ji is often cited by papers focused on Ocular Oncology and Treatments (19 papers), Retinopathy of Prematurity Studies (8 papers) and Brain Metastases and Treatment (6 papers). Xunda Ji collaborates with scholars based in China, United States and Switzerland. Xunda Ji's co-authors include Peiquan Zhao, Yu Xu, Qi Zhang, Jiao Lyu, Jia-Kai Li, Qiujing Huang, Jasmine H. Francis, David H. Abramson, Lijuan Wang and Wenxiang Zhong and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Ophthalmology and Investigative Ophthalmology & Visual Science.

In The Last Decade

Xunda Ji

30 papers receiving 534 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xunda Ji China	14	274	265	213	108	99	32	545
Mrinali P. Gupta United States	13	176 0.6×	319 1.2×	78 0.4×	66 0.6×	131 1.3×	34	520
Sourav K. Bose United States	9	54 0.2×	71 0.3×	30 0.1×	30 0.3×	235 2.4×	22	450
U. Schaller Germany	14	140 0.5×	337 1.3×	53 0.2×	12 0.1×	148 1.5×	32	520
E Foley United Kingdom	5	133 0.5×	163 0.6×	30 0.1×	22 0.2×	171 1.7×	18	379
Michael A. Naidoff United States	11	113 0.4×	216 0.8×	76 0.4×	51 0.5×	24 0.2×	14	361
Qi Wei China	13	65 0.2×	22 0.1×	28 0.1×	22 0.2×	108 1.1×	24	322
Clive Edelsten United Kingdom	18	59 0.2×	1.1k 4.1×	124 0.6×	17 0.2×	137 1.4×	36	1.3k
Laura Pelegrín Spain	17	96 0.4×	711 2.7×	118 0.6×	5 0.0×	39 0.4×	49	825
Reji Koshy Thomas India	8	22 0.1×	36 0.1×	81 0.4×	10 0.1×	81 0.8×	12	353
Laurence Desjardins France	7	47 0.2×	177 0.7×	33 0.2×	8 0.1×	13 0.1×	11	256

Countries citing papers authored by Xunda Ji

Since Specialization

Citations

This map shows the geographic impact of Xunda Ji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xunda Ji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xunda Ji more than expected).

Fields of papers citing papers by Xunda Ji

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xunda Ji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xunda Ji. The network helps show where Xunda Ji may publish in the future.

Co-authorship network of co-authors of Xunda Ji

This figure shows the co-authorship network connecting the top 25 collaborators of Xunda Ji. A scholar is included among the top collaborators of Xunda Ji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xunda Ji. Xunda Ji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Xiang, et al.. (2025). Clinical characteristics and management outcomes of pediatric patients with Coats disease complicated with retinoschisis (retinal cyst). Frontiers in Medicine. 12. 1369479–1369479.

Wen, Xuyang, Jiayan Fan, Mei Jin, et al.. (2023). Intravenous versus super-selected intra-arterial chemotherapy in children with advanced unilateral retinoblastoma: an open-label, multicentre, randomised trial. The Lancet Child & Adolescent Health. 7(9). 613–620. 21 indexed citations

Wang, Yizhuo, Dongsheng Huang, Xunda Ji, et al.. (2022). Clinical Characteristics and Image Manifestations of a Rare Retinoblastoma with a Bone Metastasis. Cancer Management and Research. Volume 14. 1565–1575. 1 indexed citations

Zhang, Xin, et al.. (2022). Intra-Arterial Chemotherapy as Primary Treatment for Advanced Unilateral Retinoblastoma in China. Frontiers in Medicine. 9. 855661–855661. 7 indexed citations

Li, Jia-Kai, Chaohui Jing, Xuming Hua, et al.. (2021). Outcome of salvage intra-arterial chemotherapy for recurrent retinoblastoma. Eye. 36(11). 2106–2110. 8 indexed citations

Zhou, Wenchuan, et al.. (2021). Weighted genes associated with the progression of retinoblastoma: Evidence from bioinformatic analysis. Experimental Eye Research. 211. 108730–108730. 7 indexed citations

Zheng, Hui, et al.. (2021). Clinical and magnetic resonance imaging features of 14 patients with trilateral retinoblastoma. Quantitative Imaging in Medicine and Surgery. 11(4). 1458–1469. 4 indexed citations

Lyu, Jiao, Yu Wang, Qiupeng Zheng, et al.. (2019). Reduction of circular RNA expression associated with human retinoblastoma. Experimental Eye Research. 184. 278–285. 31 indexed citations

Lyu, Jiao, Qi Zhang, Chunli Chen, et al.. (2019). Ranibizumab injection and laser photocoagulation to treat type 1 retinopathy of prematurity after 40 weeks post menstrual age: a retrospective case series study. BMC Ophthalmology. 19(1). 60–60. 11 indexed citations

10.

Abramson, David H., Xunda Ji, Jasmine H. Francis, et al.. (2018). Intravitreal chemotherapy in retinoblastoma: expanded use beyond intravitreal seeds. British Journal of Ophthalmology. 103(4). 488–493. 41 indexed citations

11.

Lyu, Jiao, Qi Zhang, Haiying Jin, et al.. (2018). Aqueous cytokine levels associated with severity of type 1 retinopathy of prematurity and treatment response to ranibizumab. Graefe s Archive for Clinical and Experimental Ophthalmology. 256(8). 1469–1477. 13 indexed citations

12.

Gao, Zhijie, Qian Jiang, Xilei Chen, et al.. (2018). [Study of de novo point mutations in known genes among patients with unexplained intellectual disability or developmental delay].. PubMed. 98(42). 3426–3432. 2 indexed citations

13.

Huang, Qiujing, Qi Zhang, Ping Fei, et al.. (2017). Ranibizumab Injection as Primary Treatment in Patients with Retinopathy of Prematurity. Ophthalmology. 124(8). 1156–1164. 57 indexed citations

14.

Ji, Xunda, et al.. (2016). Overexpression of KAI1 inhibits retinoblastoma metastasis in vitro. Oncology Letters. 13(2). 827–833.

15.

Liu, Yalu, Qi Zhang, Jing Li, et al.. (2016). Clinical Characteristics of Pediatric Patients with Ocular Toxocariasis in China. Ophthalmologica. 235(2). 97–105. 17 indexed citations

16.

Tian, Tian, Xunda Ji, Qi Zhang, Jie Peng, & Peiquan Zhao. (2016). A delayed diagnosis of unsuspected retinoblastoma in an in vitro fertilisation infant with retinopathy of prematurity. International Journal of Ophthalmology. 9(9). 1361–3. 2 indexed citations

17.

Ji, Xunda, et al.. (2016). Intravitreal Melphalan for Vitreous Seeds: Initial Experience in China. Journal of Ophthalmology. 2016. 1–7. 15 indexed citations

18.

Wang, Huiping, Fang Wei, Huiming Li, et al.. (2012). Combination of oncolytic adenovirus and endostatin inhibits human retinoblastoma in an in vivo mouse model. International Journal of Molecular Medicine. 31(2). 377–385. 12 indexed citations

19.

Ji, Xunda, Jufeng Zhang, Lin Cheng, et al.. (2009). Oncolytic adenovirus delivering herpes simplex virus thymidine kinase suicide gene reduces the growth of human retinoblastoma in an in vivo mouse model. Experimental Eye Research. 89(2). 193–199. 19 indexed citations

20.

Yu, Hui, Jihong Wu, Huiming Li, et al.. (2007). Inhibition of corneal neovascularization by recombinant adenovirus-mediated sFlk-1 expression. Biochemical and Biophysical Research Communications. 361(4). 946–952. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact